The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
Open accessAbstract
In order to explore potential therapeutic implications of cannabinoid antagonists, the effects of the prototypical cannabinoid antagonist SR141716A on monoamine efflux from the medial prefrontal cortex and the nucleus accumbens of the rat were investigated by in vivo microdialysis. SR141716A moderately increased serotonin efflux and concentrations of its metabolite 5‐HIAA, both in the medial prefrontal cortex and the nucleus accumbens, and increased norepinephrine, dopamine and their metabolites in the medial prefrontal cortex. In contrast, it had no effect on norepinephrine, dopamine and their metabolites in the nucleus accumbens. At the same doses, SR141716A increased acetylcholine efflux in the medial prefrontal cortex, in agreement with previous studies; contrary to the effects in cortex, SR141716A had no effect on acetylcholine efflux in the nucleus accumbens. The efficacy of SR141716A in the psychostimulant‐induced hyperlocomotion and the forced swimming paradigms was also explored in mice. SR141716A attenuated phenylcyclidine‐ and d‐amphetamine‐induced hyperlocomotion, without affecting locomotor activity when administered alone, and decreased immobility in the forced swimming test. These results suggest that the cortical selectivity in the release of catecholamines, dopamine in particular, induced by the cannabinoid antagonist SR141716A, its procholinergic properties, together with its mild stimulatory effects on serotonin and norepinephrine efflux make similar compounds unique candidates for the treatment of psychosis, affective and cognitive disorders. British Journal of Pharmacology (2003) 138, 544–553. doi:10.1038/sj.bjp.0705100
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of Depression
Baxter, L. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810030049007 · Cited by 1,320
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Self-citationLucki, I. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00010 · Cited by 802
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652
Drug addiction as dopamine-dependent associative learning disorder
Di Chiara, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 596
Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder
Biederman, J., & Spencer, T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00192-4 · Cited by 513
CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum
Gerdeman, G., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.468 · Cited by 433
A cannabinoid mechanism in relapse to cocaine seeking
De Vries, T. J., Shaham, Y., Homberg, J. R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L. J. M. J., & Schoffelmeer, A. N. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1151 · Cited by 432
The endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421
Bymaster, F. P., Zhang, W., Carter, P. A., Shaw, J., Chernet, E., Phebus, L., Wong, D. T., & Perry, K. W. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0986-x · Cited by 334
Self-citationChen, J., Paredes, W., Li, J., Smith, D., Lowinson, J., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329
Tanda, G., Carboni, E., Frau, R., & Di Chiara, G. (1994) · Psychopharmacology · doi:10.1007/bf02244785 · Cited by 320
Imperato, A., Puglisi-Allegra, S., Casolini, P., & Angelucci, L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90384-8 · Cited by 320
Behavioral Effects of Cannabinoid Agents in Animals
Chaperon, F., & Thiebot, M.-H. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i3.20 · Cited by 311
McGaughy, J., Dalley, J. W., Morrison, C. H., Everitt, B. J., & Robbins, T. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01905.2002 · Cited by 311
Robertson, G. S., Matsumura, H., & Fibiger, H. C. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23800-9 · Cited by 309
Auclair, N., Otani, S., Soubrie, P., & Crepel, F. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.6.3287 · Cited by 290
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
Terranova, J. P., Storme, J. J., Lafon, N., Pério, A., Rinaldi-Carmona, M., Le Fur, G., & Soubrié, P. (1996) · Psychopharmacology · doi:10.1007/bf02246352 · Cited by 283
Mechanisms of action of atypical antipsychotic drugs
Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253
Ichikawa, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00312-8 · Cited by 248
Zhang, W. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00119-6 · Cited by 232
COLOMBO, G., AGABIO, R., FA, M., GUANO, L., LOCHE, A., REALI, R., & GESSA, G. L. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008368 · Cited by 227
Shirazi-Southall, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00400-6 · Cited by 201
Gifford, A. N., & Ashby, C. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13092-9 · Cited by 199
Network interactions in schizophrenia — therapeutic implications
Carlsson, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00050-8 · Cited by 174
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
Lichtman, A. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00615-4 · Cited by 171
Santucci, V., Storme, J.-J., Soubrié, P., & Le Fur, G. (1996) · Life Sciences · doi:10.1016/0024-3205(95)02319-4 · Cited by 165
Gessa, G. L., Casu, M. A., Carta, G., & Mascia, M. S. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00486-5 · Cited by 142
Endocannabinoids in cognition and dependence
Lichtman, A. H., Varvel, S. A., & Martin, B. R. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0351 · Cited by 138
Linnér, L., Endersz, H., Öhman, D., Bengtsson, F., Schalling, M., & Svensson, T. H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29568-9 · Cited by 128
Cadogan, A., Alexander, S. P. H., Boyd, E. A., & Kendall, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031131.x · Cited by 127
Nomikos, G. G., Iurlo, M., Andersson, J. L., Kimura, K., & Svensson, T. H. (1994) · Psychopharmacology · doi:10.1007/bf02244765 · Cited by 123
Self-citationNieto, M. M., Pommier, B., Tzavara, E. T., Caneparo, A., Nascimento, S. D., Fur, G. L., Roques, B. P., & Noble, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703990 · Cited by 122
Self-citationSzabó, B., Müller, T., & Koch, H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731084.x · Cited by 120
Westerink, B. H. C., Kawahara, Y., Boer, P. D., Geels, C., Vries, J. B. D., Wikström, H., Kalkeren, A. A. V., Vliet, B. J. V., Kruse, C. G., & Long, S. K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00935-3 · Cited by 120
(R)‐8‐OH‐DPAT preferentially increases dopamine release in rat medial prefrontal cortex
Arborelius, L., Nomikos, G. G., Hacksell, U., & Svensson, T. H. (1993) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1993.tb09584.x · Cited by 102
Self-citationKathmann, M., Bauer, U. S., Schlicker, E., et al. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005377 · Cited by 89
Acquas, E., Pisanu, A., Marrocu, P., & Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00403-9 · Cited by 83
Alonso, R., Voutsinos‐Porche, B., Fournier, M., Labie, C., Steinberg, R., Souilhac, J., Fur, G. L., & Soubrié, P. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00675-7 · Cited by 83
Tzavara, E. T., Perry, K. W., Rodriguez, D. E., Bymaster, F. P., & Nomikos, G. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01228-6 · Cited by 71
Self-citationFowler, C. J., & Jacobsson, S. O. P. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0357 · Cited by 69
Poncelet, M., Barnouin, M. C., Brelière, J.-C., Fur, G. L., & Soubrié, P. (1999) · Psychopharmacology · doi:10.1007/s002130050987 · Cited by 66
Perry, K. W., & Fuller, R. W. (1997) · Journal of Neural Transmission · doi:10.1007/bf01285563 · Cited by 62
Self-citationAcquas, E., Pisanu, A., Marrocu, P., et al. (2000) · UNICA IRIS Institutional Research Information System (University of Cagliari) · Cited by 56
Masserano, J. M., Karoum, F., & Wyatt, R. J. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199907000-00010 · Cited by 48
Moor, E., Schirm, E., Jacsó, J., & Westerink, B. H. C. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00331-x · Cited by 41
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527
Patel, S., Roelke, C. T., Rademacher, D. J., & Hillard, C. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03916.x · Cited by 297
Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
Hill, M., Miller, G., Ho, W.-S., Gorzalka, B., & Hillard, C. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-993211 · Cited by 292
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Le Foll, B., & Goldberg, S. R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 291
Metadata
- Authors
- Tzavara, E. T., Davis, R. J., Perry, K. W., Li, X., Salhoff, C., Bymaster, F. P., Witkin, J. M., & Nomikos, G. G.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-02
- Volume
- 138
- Issue
- 4
- Pages
- 544-553
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2160184530
- Cited by
- 269
- References
- 54
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.